-
1
-
-
64849086921
-
Synergism of EGFR and c-Met pathways, cross-talk and inhibition, in non-small cell lung cancer
-
19240370
-
Puri N, Salgia R (2008) Synergism of EGFR and c-Met pathways, cross-talk and inhibition, in non-small cell lung cancer. J Carcinog 7:9. PMID: 19240370
-
(2008)
J Carcinog
, vol.7
, pp. 9
-
-
Puri, N.1
Salgia, R.2
-
2
-
-
34249075147
-
MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling
-
17463250
-
Engelman JA, Zejnullahu K, Mitsudomi T, Song Y, Hyland C, Park JO, et al. (2007) MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. Science 316:1039-1043. PMID: 17463250
-
(2007)
Science
, vol.316
, pp. 1039-1043
-
-
Engelman, J.A.1
Zejnullahu, K.2
Mitsudomi, T.3
Song, Y.4
Hyland, C.5
Park, J.O.6
-
3
-
-
84875914687
-
MET as a possible target for non-small-cell lung cancer
-
23401458
-
Sadiq AA, Salgia R (2013) MET as a possible target for non-small-cell lung cancer. J Clin Oncol 31:1089-1096. doi: 10.1200/JCO.2012.43.9422 PMID: 23401458
-
(2013)
J Clin Oncol
, vol.31
, pp. 1089-1096
-
-
Sadiq, A.A.1
Salgia, R.2
-
4
-
-
80051974548
-
Randomized phase II study of erlotinib plus tivantinib versus erlotinib plus placebo in previously treated non-small-cell lung cancer
-
21768463
-
Sequist LV, Von Pawel J, Garmey EG, Akerley WL, Brugger W, Ferrari D, et al. (2011) Randomized phase II study of erlotinib plus tivantinib versus erlotinib plus placebo in previously treated non-small-cell lung cancer. J Clin Oncol 29:3307-3315. doi: 10.1200/JCO.2010.34.0570 PMID: 21768463
-
(2011)
J Clin Oncol
, vol.29
, pp. 3307-3315
-
-
Sequist, L.V.1
Von Pawel, J.2
Garmey, E.G.3
Akerley, W.L.4
Brugger, W.5
Ferrari, D.6
-
5
-
-
77952238683
-
Epidermal growth factor receptor regulates MET levels and invasiveness through hypoxia-inducible factor-1alpha in non-small cell lung cancer cells
-
20154724
-
Xu L, Nilsson MB, Saintigny P, Cascone T, Herynk MH, Du Z, et al. (2010) Epidermal growth factor receptor regulates MET levels and invasiveness through hypoxia-inducible factor-1alpha in non-small cell lung cancer cells. Oncogene 29:2616-2627. doi: 10.1038/onc.2010.16 PMID: 20154724
-
(2010)
Oncogene
, vol.29
, pp. 2616-2627
-
-
Xu, L.1
Nilsson, M.B.2
Saintigny, P.3
Cascone, T.4
Herynk, M.H.5
Du, Z.6
-
6
-
-
77950678272
-
Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapy
-
20385023
-
Sierra JR, Cepero V, Giordano S (2010) Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapy. Mol Cancer 9:75. doi: 10.1186/1476-4598-9-75 PMID: 20385023
-
(2010)
Mol Cancer
, vol.9
, pp. 75
-
-
Sierra, J.R.1
Cepero, V.2
Giordano, S.3
-
7
-
-
84874065941
-
Local therapy with continued EGFR tyrosine kinase inhibitor therapy as a treatment strategy in EGFR-mutant advanced lung cancers that have developed acquired resistance to EGFR tyrosine kinase inhibitors
-
23407558
-
Yu HA, Sima CS, Huang J, Solomon SB, Rimner A, Paik P, et al. (2013) Local therapy with continued EGFR tyrosine kinase inhibitor therapy as a treatment strategy in EGFR-mutant advanced lung cancers that have developed acquired resistance to EGFR tyrosine kinase inhibitors. JThoracOncol 8:346-351. doi: 10.1097/JTO.0b013e31827e1f83 PMID: 23407558
-
(2013)
JThoracOncol
, vol.8
, pp. 346-351
-
-
Yu, H.A.1
Sima, C.S.2
Huang, J.3
Solomon, S.B.4
Rimner, A.5
Paik, P.6
-
8
-
-
68949201629
-
Activating and resistance mutations of EGFR in non-small-cell lung cancer: Role in clinical response to EGFR tyrosine kinase inhibitors
-
19680293
-
Gazdar AF (2009) Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors. Oncogene 28 Suppl 1:S24-31. doi: 10.1038/onc. 2009.198 PMID: 19680293
-
(2009)
Oncogene
, vol.28
, pp. S24-S31
-
-
Gazdar, A.F.1
-
9
-
-
84856266000
-
Drug development to overcome resistance to EGFR inhibitors in lung and colorectal cancer
-
22189054
-
Dienstmann R, De Dosso S, Felip E, Tabernero J (2012) Drug development to overcome resistance to EGFR inhibitors in lung and colorectal cancer. Mol Oncol 6:15-26. doi: 10.1016/j.molonc.2011.11.009 PMID: 22189054
-
(2012)
Mol Oncol
, vol.6
, pp. 15-26
-
-
Dienstmann, R.1
De Dosso, S.2
Felip, E.3
Tabernero, J.4
-
10
-
-
13844317894
-
EGFR mutation and resistance of non-small-cell lung cancerto gefitinib
-
15728811
-
Kobayashi S, Boggon TJ, Dayaram T, Janne PA, Kocher O, Meyerson M, et al. (2005) EGFR mutation and resistance of non-small-cell lung cancerto gefitinib. N Engl J Med 352:786-792. PMID: 15728811
-
(2005)
N Engl J Med
, vol.352
, pp. 786-792
-
-
Kobayashi, S.1
Boggon, T.J.2
Dayaram, T.3
Janne, P.A.4
Kocher, O.5
Meyerson, M.6
-
11
-
-
33751292685
-
Novel D761Y and common secondary T790M mutations in epidermal growth factor receptor-mutant lung adenocarcinomas with acquired resistance to kinase inhibitors
-
17085664
-
Balak MN, Gong Y, Riely GJ, Somwar R, Li AR, Zakowski MF, et al. (2006) Novel D761Y and common secondary T790M mutations in epidermal growth factor receptor-mutant lung adenocarcinomas with acquired resistance to kinase inhibitors. Clin Cancer Res 12:6494-6501. PMID: 17085664
-
(2006)
Clin Cancer Res
, vol.12
, pp. 6494-6501
-
-
Balak, M.N.1
Gong, Y.2
Riely, G.J.3
Somwar, R.4
Li, A.R.5
Zakowski, M.F.6
-
12
-
-
33750302365
-
Analysis of epidermal growth factor receptor gene mutation in patients with non-small cell lung cancer and acquired resistance to gefitinib
-
17020982
-
Kosaka T, Yatabe Y, Endoh H, Yoshida K, Hida T, Tsuboi M, et al. (2006) Analysis of epidermal growth factor receptor gene mutation in patients with non-small cell lung cancer and acquired resistance to gefitinib. Clin Cancer Res 12:5764-5769. PMID: 17020982
-
(2006)
Clin Cancer Res
, vol.12
, pp. 5764-5769
-
-
Kosaka, T.1
Yatabe, Y.2
Endoh, H.3
Yoshida, K.4
Hida, T.5
Tsuboi, M.6
-
13
-
-
38049150665
-
MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib
-
18093943
-
Bean J, Brennan C, Shih JY, Riely G, Viale A, Wang L, et al. (2007) MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib. Proc Natl Acad Sci USA 104:20932-20937. PMID: 18093943
-
(2007)
Proc Natl Acad Sci U S A
, vol.104
, pp. 20932-20937
-
-
Bean, J.1
Brennan, C.2
Shih, J.Y.3
Riely, G.4
Viale, A.5
Wang, L.6
-
14
-
-
73649102105
-
Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC
-
20129249
-
Turke AB, Zejnullahu K, Wu YL, Song Y, Dias-Santagata D, Lifshits E, et al. (2010) Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC. Cancer Cell 17:77-88. doi: 10.1016/j. ccr.2009.11.022 PMID: 20129249
-
(2010)
Cancer Cell
, vol.17
, pp. 77-88
-
-
Turke, A.B.1
Zejnullahu, K.2
Wu, Y.L.3
Song, Y.4
Dias-Santagata, D.5
Lifshits, E.6
-
15
-
-
0028181118
-
Tyrosines1234-1235 are critical for activation of the tyrosine kinase encoded by the MET proto-oncogene (HGF receptor)
-
8302603
-
Longati P, Bardelli A, Ponzetto C, Naldini L, Comoglio PM (1994) Tyrosines1234-1235 are critical for activation of the tyrosine kinase encoded by the MET proto-oncogene (HGF receptor). Oncogene 9:49-57. PMID: 8302603
-
(1994)
Oncogene
, vol.9
, pp. 49-57
-
-
Longati, P.1
Bardelli, A.2
Ponzetto, C.3
Naldini, L.4
Comoglio, P.M.5
-
16
-
-
34250186410
-
Cross talk between c-Met and epidermal growth factor receptor during retinal pigment epithelial wound healing
-
17460286
-
Xu KP, Yu FS (2007) Cross talk between c-Met and epidermal growth factor receptor during retinal pigment epithelial wound healing. Invest Ophthalmol Vis Sci 48:2242-2248. PMID: 17460286
-
(2007)
Invest Ophthalmol Vis Sci
, vol.48
, pp. 2242-2248
-
-
Xu, K.P.1
Yu, F.S.2
-
17
-
-
84892607231
-
Alternative signaling pathways as potential therapeutic targets for overcoming EGFR and c-Met inhibitor resistance in non-small cell lung cancer
-
24223799
-
Fong JT, Jacobs RJ, Moravec DN, Uppada SB, Botting GM, Nlend M, et al. (2013) Alternative signaling pathways as potential therapeutic targets for overcoming EGFR and c-Met inhibitor resistance in non-small cell lung cancer. PLoS One 8:e78398. doi: 10.1371/journal.pone.0078398 PMID: 24223799
-
(2013)
PLoS One
, vol.8
, pp. e78398
-
-
Fong, J.T.1
Jacobs, R.J.2
Moravec, D.N.3
Uppada, S.B.4
Botting, G.M.5
Nlend, M.6
-
18
-
-
77956471611
-
Convergence between Wnt-beta-catenin and EGFR signaling in cancer
-
20828404
-
Hu T, Li C (2010) Convergence between Wnt-beta-catenin and EGFR signaling in cancer. Mol Cancer 9:236. doi: 10.1186/1476-4598-9-236 PMID: 20828404
-
(2010)
Mol Cancer
, vol.9
, pp. 236
-
-
Hu, T.1
Li, C.2
-
19
-
-
65349127013
-
Noncanonical Wnt signaling in tumor progression and metastasis
-
19292672
-
Jessen JR (2009) Noncanonical Wnt signaling in tumor progression and metastasis. Zebrafish 6:21-28. doi: 10.1089/zeb.2008.0571 PMID: 19292672
-
(2009)
Zebrafish
, vol.6
, pp. 21-28
-
-
Jessen, J.R.1
-
20
-
-
84891551331
-
Current understanding on EGFR and Wnt/beta-catenin signaling in glioma and their possible crosstalk
-
24386505
-
Paul I, Bhattacharya S, Chatterjee A, Ghosh MK (2013) Current Understanding on EGFR and Wnt/beta-Catenin Signaling in Glioma and Their Possible Crosstalk. Genes Cancer 4:427-446. doi: 10. 1177/1947601913503341 PMID: 24386505
-
(2013)
Genes Cancer
, vol.4
, pp. 427-446
-
-
Paul, I.1
Bhattacharya, S.2
Chatterjee, A.3
Ghosh, M.K.4
-
21
-
-
70349695861
-
Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
-
19759537
-
Huang SM, Mishina YM, Liu S, Cheung A, Stegmeier F, Michaud GA, et al. (2009) Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature 461:614-620. doi: 10.1038/nature08356 PMID: 19759537
-
(2009)
Nature
, vol.461
, pp. 614-620
-
-
Huang, S.M.1
Mishina, Y.M.2
Liu, S.3
Cheung, A.4
Stegmeier, F.5
Michaud, G.A.6
-
22
-
-
0036632368
-
The phosphatidylinositol 3-Kinase AKT pathway in human cancer
-
12094235
-
Vivanco I, Sawyers CL (2002) The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2:489-501. PMID: 12094235
-
(2002)
Nat Rev Cancer
, vol.2
, pp. 489-501
-
-
Vivanco, I.1
Sawyers, C.L.2
-
23
-
-
34047095297
-
The two TORCs and Akt
-
17419990
-
Bhaskar PT, Hay N (2007) The two TORCs and Akt. Dev Cell 12:487-502. PMID: 17419990
-
(2007)
Dev Cell
, vol.12
, pp. 487-502
-
-
Bhaskar, P.T.1
Hay, N.2
-
24
-
-
68249093818
-
Targeting the phosphoinositide 3-kinase pathway in cancer
-
19644473
-
Liu P, Cheng H, Roberts TM, Zhao JJ (2009) Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev Drug Discov 8:627-644. doi: 10.1038/nrd2926 PMID: 19644473
-
(2009)
Nat Rev Drug Discov
, vol.8
, pp. 627-644
-
-
Liu, P.1
Cheng, H.2
Roberts, T.M.3
Zhao, J.J.4
-
25
-
-
38149108890
-
All roads lead to mTOR: Integrating inflammation and tumor angiogenesis
-
18073529
-
Lee DF, Hung MC (2007) All roads lead to mTOR: integrating inflammation and tumor angiogenesis. Cell Cycle 6:3011-3014. PMID: 18073529
-
(2007)
Cell Cycle
, vol.6
, pp. 3011-3014
-
-
Lee, D.F.1
Hung, M.C.2
-
26
-
-
84861312838
-
The mTOR pathway in lung cancer and implications for therapy and biomarkeranalysis
-
22588151
-
Ekman S, Wynes MW, Hirsch FR (2012) The mTOR pathway in lung cancer and implications for therapy and biomarkeranalysis. JThoracOncol 7:947-953. doi: 10.1097/JTO.0b013e31825581bd PMID: 22588151
-
(2012)
JThoracOncol
, vol.7
, pp. 947-953
-
-
Ekman, S.1
Wynes, M.W.2
Hirsch, F.R.3
-
27
-
-
40349106029
-
The potential role of mTOR inhibitors in non-small cell lung cancer
-
18305058
-
Gridelli C, Maione P, Rossi A (2008) The potential role of mTOR inhibitors in non-small cell lung cancer. Oncologist 13:139-147. doi: 10.1634/theoncologist.2007-0171 PMID: 18305058
-
(2008)
Oncologist
, vol.13
, pp. 139-147
-
-
Gridelli, C.1
Maione, P.2
Rossi, A.3
-
28
-
-
70349637311
-
Efficacy of everolimus (RAD001) in patients with advanced NSCLC previously treated with chemotherapy alone or with chemotherapy and EGFR inhibitors
-
19549709
-
Soria JC, Shepherd FA, Douillard JY, Wolf J, Giaccone G, Crino L, et al. (2009) Efficacy of everolimus (RAD001) in patients with advanced NSCLC previously treated with chemotherapy alone or with chemotherapy and EGFR inhibitors. Ann Oncol 20:1674-1681. doi: 10.1093/annonc/mdp060 PMID: 19549709
-
(2009)
Ann Oncol
, vol.20
, pp. 1674-1681
-
-
Soria, J.C.1
Shepherd, F.A.2
Douillard, J.Y.3
Wolf, J.4
Giaccone, G.5
Crino, L.6
-
31
-
-
33748168778
-
Mind the GAP: Wnt steps onto the mTORC1 train
-
16959561
-
Choo AY, Roux PP, Blenis J (2006) Mind the GAP: Wnt steps onto the mTORC1 train. Cell 126:834-836. PMID: 16959561
-
(2006)
Cell
, vol.126
, pp. 834-836
-
-
Choo, A.Y.1
Roux, P.P.2
Blenis, J.3
-
32
-
-
33748153690
-
TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth
-
16959574
-
Inoki K, Ouyang H, Zhu T, Lindvall C, Wang Y, Zhang X, et al. (2006) TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell 126:955-968. PMID: 16959574
-
(2006)
Cell
, vol.126
, pp. 955-968
-
-
Inoki, K.1
Ouyang, H.2
Zhu, T.3
Lindvall, C.4
Wang, Y.5
Zhang, X.6
-
33
-
-
84902094632
-
GSK-3as potential target for therapeutic intervention in cancer
-
24931005
-
McCubrey JA, Steelman LS, Bertrand FE, Davis NM, Sokolosky M, Abrams SL, et al. (2014) GSK-3as potential target for therapeutic intervention in cancer. Oncotarget 5:2881-2911. PMID: 24931005
-
(2014)
Oncotarget
, vol.5
, pp. 2881-2911
-
-
McCubrey, J.A.1
Steelman, L.S.2
Bertrand, F.E.3
Davis, N.M.4
Sokolosky, M.5
Abrams, S.L.6
-
34
-
-
84872016448
-
The beta-catenin destruction complex
-
23169527
-
Stamos JL, Weis WI (2013) The beta-catenin destruction complex. Cold Spring Harb Perspect Biol 5:a007898. doi: 10.1101/cshperspect.a007898 PMID: 23169527
-
(2013)
Cold Spring Harb Perspect Biol
, vol.5
, pp. a007898
-
-
Stamos, J.L.1
Weis, W.I.2
-
35
-
-
34249311572
-
Functional redundancy of GSK-3alpha and GSK-3beta in Wnt/beta-catenin signaling shown by using an allelic series of embryonic stem cell lines
-
17543867
-
Doble BW, Patel S, Wood GA, Kockeritz LK, Woodgett JR (2007) Functional redundancy of GSK-3alpha and GSK-3beta in Wnt/beta-catenin signaling shown by using an allelic series of embryonic stem cell lines. DevCell 12:957-971. PMID: 17543867
-
(2007)
DevCell
, vol.12
, pp. 957-971
-
-
Doble, B.W.1
Patel, S.2
Wood, G.A.3
Kockeritz, L.K.4
Woodgett, J.R.5
-
36
-
-
0037383322
-
GSK-3: Tricks of the trade for a multi-tasking kinase
-
12615961
-
Doble BW, Woodgett JR(2003) GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci 116:1175-1186. PMID: 12615961
-
(2003)
J Cell Sci
, vol.116
, pp. 1175-1186
-
-
Doble, B.W.1
Woodgett, J.R.2
-
37
-
-
46249127489
-
A Gata6-Wnt pathway required for epithelial stem cell development and airway regeneration
-
18536717
-
Zhang Y, Goss AM, Cohen ED, Kadzik R, Lepore JJ, Muthukumaraswamy K, et al. (2008) A Gata6-Wnt pathway required for epithelial stem cell development and airway regeneration. Nat Genet 40:862-870. doi: 10.1038/ng.157 PMID: 18536717
-
(2008)
Nat Genet
, vol.40
, pp. 862-870
-
-
Zhang, Y.1
Goss, A.M.2
Cohen, E.D.3
Kadzik, R.4
Lepore, J.J.5
Muthukumaraswamy, K.6
-
38
-
-
0032590183
-
The transcription factor GATA6 is essential for early extraembryonic development
-
Koutsourakis M, Langeveld A, Patient R, Beddington R, Grosveld F (1999) The transcription factor GATA6 is essential for early extraembryonic development. Development 126:723-732.
-
(1999)
Development
, vol.126
, pp. 723-732
-
-
Koutsourakis, M.1
Langeveld, A.2
Patient, R.3
Beddington, R.4
Grosveld, F.5
-
39
-
-
50049127672
-
Oncogenic Ras upregulates NADPH oxidase 1 gene expression through MEK-ERK-dependent phosphorylation of GATA-6
-
18454176
-
Adachi Y, Shibai Y, Mitsushita J, Shang WH, Hirose K, Kamata T (2008) Oncogenic Ras upregulates NADPH oxidase 1 gene expression through MEK-ERK-dependent phosphorylation of GATA-6. Oncogene 27:4921-4932. doi: 10.1038/onc.2008.133 PMID: 18454176
-
(2008)
Oncogene
, vol.27
, pp. 4921-4932
-
-
Adachi, Y.1
Shibai, Y.2
Mitsushita, J.3
Shang, W.H.4
Hirose, K.5
Kamata, T.6
-
40
-
-
38549095978
-
Low-density lipoprotein receptor-related protein 5 (LRP5) mediates the prostate cancer-induced formation of new bone
-
17700537
-
Li ZG, Yang J, Vazquez ES, Rose D, Vakar-Lopez F, Mathew P, et al. (2008) Low-density lipoprotein receptor-related protein 5 (LRP5) mediates the prostate cancer-induced formation of new bone. Oncogene 27:596-603. PMID: 17700537
-
(2008)
Oncogene
, vol.27
, pp. 596-603
-
-
Li, Z.G.1
Yang, J.2
Vazquez, E.S.3
Rose, D.4
Vakar-Lopez, F.5
Mathew, P.6
-
41
-
-
0037036408
-
The WNT7b promoter is regulated by TTF-1, GATA6, and Foxa2in lung epithelium
-
11914369
-
Weidenfeld J, Shu W, Zhang L, Millar SE, Morrisey EE (2002) The WNT7b promoter is regulated by TTF-1, GATA6, and Foxa2in lung epithelium. J Biol Chem 277:21061-21070. PMID: 11914369
-
(2002)
J Biol Chem
, vol.277
, pp. 21061-21070
-
-
Weidenfeld, J.1
Shu, W.2
Zhang, L.3
Millar, S.E.4
Morrisey, E.E.5
-
42
-
-
33846621582
-
Down-regulation of Wnt signal pathway in nitrofen-induced hypoplastic lung
-
17270562
-
Takayasu H, Nakazawa N, Montedonico S, Puri P (2007) Down-regulation of Wnt signal pathway in nitrofen-induced hypoplastic lung. J PediatrSurg 42:426-430. PMID: 17270562
-
(2007)
J PediatrSurg
, vol.42
, pp. 426-430
-
-
Takayasu, H.1
Nakazawa, N.2
Montedonico, S.3
Puri, P.4
-
43
-
-
14044252936
-
Both ERK and Wnt/beta-catenin pathways are involved in Wnt3a-induced proliferation
-
15615777
-
Yun MS, Kim SE, Jeon SH, Lee JS, Choi KY (2005) Both ERK and Wnt/beta-catenin pathways are involved in Wnt3a-induced proliferation. J Cell Sci 118:313-322. PMID: 15615777
-
(2005)
J Cell Sci
, vol.118
, pp. 313-322
-
-
Yun, M.S.1
Kim, S.E.2
Jeon, S.H.3
Lee, J.S.4
Choi, K.Y.5
-
44
-
-
67650230896
-
Wnt/beta-catenin signaling: Components, mechanisms, and diseases
-
19619488
-
MacDonald BT, Tamai K, He X (2009) Wnt/beta-catenin signaling: components, mechanisms, and diseases. DevCell 17:9-26. doi: 10.1016/j.devcel.2009.06.016 PMID: 19619488
-
(2009)
DevCell
, vol.17
, pp. 9-26
-
-
MacDonald, B.T.1
Tamai, K.2
He, X.3
-
45
-
-
45849117967
-
Wnt signal transduction pathways
-
19279717
-
Komiya Y, Habas R (2008) Wnt signal transduction pathways. Organogenesis 4:68-75. PMID: 19279717
-
(2008)
Organogenesis
, vol.4
, pp. 68-75
-
-
Komiya, Y.1
Habas, R.2
-
46
-
-
84906854269
-
Targeting c-Met in melanoma: Mechanism of resistance and efficacy of novel combinatorial inhibitor therapy
-
24914950
-
Etnyre D, Stone AL, Fong JT, Jacobs RJ, Uppada SB, Botting GM, et al. (2014) Targeting c-Met in melanoma: Mechanism of resistance and efficacy of novel combinatorial inhibitor therapy. Cancer Biol Ther 15:1129-1141. doi: 10.4161/cbt.29451 PMID: 24914950
-
(2014)
Cancer Biol Ther
, vol.15
, pp. 1129-1141
-
-
Etnyre, D.1
Stone, A.L.2
Fong, J.T.3
Jacobs, R.J.4
Uppada, S.B.5
Botting, G.M.6
-
47
-
-
0033486152
-
Beta-catenin signaling and cancer
-
10580987
-
Morin PJ (1999) beta-catenin signaling and cancer. Bioessays 21:1021-1030. PMID: 10580987
-
(1999)
Bioessays
, vol.21
, pp. 1021-1030
-
-
Morin, P.J.1
-
48
-
-
57349143530
-
Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy
-
18606491
-
Luo J (2009) Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy. Cancer Lett 273:194-200. doi: 10.1016/j.canlet.2008.05.045 PMID: 18606491
-
(2009)
Cancer Lett
, vol.273
, pp. 194-200
-
-
Luo, J.1
-
49
-
-
0037163032
-
Phosphatidylinositol 3-kinase/Akt stimulates androgen pathway through GSK3beta inhibition and nuclear beta-catenin accumulation
-
12063252
-
Sharma M, Chuang WW, Sun Z (2002) Phosphatidylinositol 3-kinase/Akt stimulates androgen pathway through GSK3beta inhibition and nuclear beta-catenin accumulation. J Biol Chem 277:30935-30941. PMID: 12063252
-
(2002)
J Biol Chem
, vol.277
, pp. 30935-30941
-
-
Sharma, M.1
Chuang, W.W.2
Sun, Z.3
-
50
-
-
13944269898
-
The AKT/I kappa B kinase pathway promotes angiogenic/metastatic gene expression in colorectal cancer by activating nuclearfactor-kappaBand beta-catenin
-
15592509
-
Agarwal A, Das K, Lerner N, Sathe S, Cicek M, Casey G, et al. (2005) The AKT/I kappa B kinase pathway promotes angiogenic/metastatic gene expression in colorectal cancer by activating nuclearfactor-kappaBand beta-catenin. Oncogene 24:1021-1031. PMID: 15592509
-
(2005)
Oncogene
, vol.24
, pp. 1021-1031
-
-
Agarwal, A.1
Das, K.2
Lerner, N.3
Sathe, S.4
Cicek, M.5
Casey, G.6
-
51
-
-
0037151060
-
ErbB-beta-catenin complexes are associated with human infiltrating ductal breast and murine mammary tumor virus (MMTV)-Wnt-1 and MMTV-c-Neu transgenic carcinomas
-
11950845
-
Schroeder JA, Adriance MC, McConnell EJ, Thompson MC, Pockaj B, Gendler SJ (2002) ErbB-beta-catenin complexes are associated with human infiltrating ductal breast and murine mammary tumor virus (MMTV)-Wnt-1 and MMTV-c-Neu transgenic carcinomas. J Biol Chem 277:22692-22698. PMID: 11950845
-
(2002)
J Biol Chem
, vol.277
, pp. 22692-22698
-
-
Schroeder, J.A.1
Adriance, M.C.2
McConnell, E.J.3
Thompson, M.C.4
Pockaj, B.5
Gendler, S.J.6
-
52
-
-
84865145584
-
Tankyrase and the canonical Wnt pathway protect lung cancer cells from EGFR inhibition
-
22738915
-
Casas-Selves M, Kim J, Zhang Z, Helfrich BA, Gao D, Porter CC, et al. (2012) Tankyrase and the canonical Wnt pathway protect lung cancer cells from EGFR inhibition. Cancer Res 72:4154-4164. doi: 10.1158/0008-5472. CAN-11-2848 PMID: 22738915
-
(2012)
Cancer Res
, vol.72
, pp. 4154-4164
-
-
Casas-Selves, M.1
Kim, J.2
Zhang, Z.3
Helfrich, B.A.4
Gao, D.5
Porter, C.C.6
-
53
-
-
0345736990
-
Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion
-
14706341
-
Lu Z, Ghosh S, Wang Z, Hunter T (2003) Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion. CancerCell 4:499-515. PMID: 14706341
-
(2003)
CancerCell
, vol.4
, pp. 499-515
-
-
Lu, Z.1
Ghosh, S.2
Wang, Z.3
Hunter, T.4
-
54
-
-
79955496473
-
Wnt/beta-catenin signaling accelerates mouse lung tumorigenesis by imposing an embryonic distal progenitor phenotypeon lung epithelium
-
21490395
-
Pacheco-Pinedo EC, Durham AC, Stewart KM, Goss AM, Lu MM, Demayo FJ, et al. (2011) Wnt/beta-catenin signaling accelerates mouse lung tumorigenesis by imposing an embryonic distal progenitor phenotypeon lung epithelium. J Clin Invest 121:1935-1945. doi: 10.1172/JCI44871 PMID: 21490395
-
(2011)
J Clin Invest
, vol.121
, pp. 1935-1945
-
-
Pacheco-Pinedo, E.C.1
Durham, A.C.2
Stewart, K.M.3
Goss, A.M.4
Lu, M.M.5
Demayo, F.J.6
-
55
-
-
0034729754
-
Cooperative induction of mammary tumorigenesis by TGFalpha and Wnts
-
10918574
-
Schroeder JA, Troyer KL, Lee DC (2000) Cooperative induction of mammary tumorigenesis by TGFalpha and Wnts. Oncogene 19:3193-3199. PMID: 10918574
-
(2000)
Oncogene
, vol.19
, pp. 3193-3199
-
-
Schroeder, J.A.1
Troyer, K.L.2
Lee, D.C.3
-
56
-
-
77649129121
-
GSK3: A multifaceted kinase in Wnt signaling
-
19884009
-
Wu D, Pan W (2010) GSK3: a multifaceted kinase in Wnt signaling. Trends Biochem Sci 35:161-168. doi: 10.1016/j.tibs.2009.10.002 PMID: 19884009
-
(2010)
Trends Biochem Sci
, vol.35
, pp. 161-168
-
-
Wu, D.1
Pan, W.2
-
57
-
-
79960470568
-
GATA6 activates Wnt signaling in pancreatic cancer by negatively regulating the Wnt antagonist Dickkopf-1
-
21811562
-
Zhong Y, Wang Z, Fu B, Pan F, Yachida S, Dhara M, et al. (2011) GATA6 activates Wnt signaling in pancreatic cancer by negatively regulating the Wnt antagonist Dickkopf-1. PLoSOne 6:e22129. doi: 10.1371/journal.pone.0022129 PMID: 21811562
-
(2011)
PLoSOne
, vol.6
, pp. e22129
-
-
Zhong, Y.1
Wang, Z.2
Fu, B.3
Pan, F.4
Yachida, S.5
Dhara, M.6
-
58
-
-
34248591612
-
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
-
17496923
-
Roberts PJ, der CJ (2007) Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 26:3291-3310. PMID: 17496923
-
(2007)
Oncogene
, vol.26
, pp. 3291-3310
-
-
Roberts, P.J.1
Der, C.J.2
-
59
-
-
84875431178
-
Caveolin-1-LRP6 signaling module stimulates aerobic glycolysis in prostate cancer
-
23302227
-
Tahir SA, Yang G, Goltsov A, Song KD, Ren C, Wang J, et al. (2013) Caveolin-1-LRP6 signaling module stimulates aerobic glycolysis in prostate cancer. Cancer Res 73:1900-1911. doi: 10.1158/0008-5472. CAN-12-3040 PMID: 23302227
-
(2013)
Cancer Res
, vol.73
, pp. 1900-1911
-
-
Tahir, S.A.1
Yang, G.2
Goltsov, A.3
Song, K.D.4
Ren, C.5
Wang, J.6
-
60
-
-
84894523716
-
Making new contacts: The mTOR network in metabolism and signalling crosstalk
-
24556838
-
Shimobayashi M, Hall MN (2014) Making new contacts: the mTOR network in metabolism and signalling crosstalk. Nat RevMol Cell Biol 15:155-162. doi: 10.1038/nrm3757 PMID: 24556838
-
(2014)
Nat RevMol Cell Biol
, vol.15
, pp. 155-162
-
-
Shimobayashi, M.1
Hall, M.N.2
-
61
-
-
79958020132
-
EGFR-mutated lung cancer: A paradigm of molecular oncology
-
21165163
-
Zhang Z, Stiegler AL, Boggon TJ, Kobayashi S, Halmos B (2010) EGFR-mutated lung cancer: a paradigm of molecular oncology. Oncotarget 1:497-514. PMID: 21165163
-
(2010)
Oncotarget
, vol.1
, pp. 497-514
-
-
Zhang, Z.1
Stiegler, A.L.2
Boggon, T.J.3
Kobayashi, S.4
Halmos, B.5
-
62
-
-
77955763968
-
The combination of multiple receptor tyrosine kinase inhibitor and mammalian target of rapamycin inhibitor overcomes erlotinib resistance in lung cancer cell lines through c-Met inhibition
-
20647329
-
Nakachi I, Naoki K, Soejima K, Kawada I, Watanabe H, Yasuda H, et al. (2010) The combination of multiple receptor tyrosine kinase inhibitor and mammalian target of rapamycin inhibitor overcomes erlotinib resistance in lung cancer cell lines through c-Met inhibition. Mol Cancer Res 8:1142-1151. doi: 10. 1158/1541-7786. MCR-09-0388 PMID: 20647329
-
(2010)
Mol Cancer Res
, vol.8
, pp. 1142-1151
-
-
Nakachi, I.1
Naoki, K.2
Soejima, K.3
Kawada, I.4
Watanabe, H.5
Yasuda, H.6
|